In 2023, Australia led in hospital discharges for soft tissue disorders with 73.05 thousand cases, marking a 3.03% increase from previous years. The United Kingdom followed with 50.66 thousand discharges, showing a 1.54% decrease. Switzerland reported 25.83 thousand discharges, experiencing a 1.12% rise. Belgium had 21.99 thousand cases, witnessing a slight decrease of 0.41%. Portugal recorded the lowest at 3.54 thousand. Over the last five years, compound annual growth rates have varied, highlighting unique national trends.
Future trends to watch include:
- Potential growth in demand for advanced soft tissue disorder treatments in Australia and Switzerland.
- Continued analysis of healthcare policy impacts in the UK and Belgium.
- Opportunities for improving healthcare infrastructure in Portugal to manage cases more effectively.
Top countries in Hospital Discharges for Soft Tissue Disorders Cases by Country
| # | 5 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Australia | 73,050 | 2023 | +3.38% | +3.03% | View data |
| 2 | 2 United Kingdom | 50,660 | 2023 | -1.85% | -1.54% | View data |
| 3 | 3 Switzerland | 25,830 | 2023 | +2.2% | +1.12% | View data |
| 4 | 4 Belgium | 21,990 | 2023 | +6.18% | -0.41% | View data |
| 5 | 5 Portugal | 3,540 | 2021 | +18.59% | View data |
